Epithelial lining fluid neutrophil-gelatinase-associated lipocalin levels in premature newborns with bronchopulmonary dysplasia and patency of ductus arteriosus

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 1, 2008, Pages 173-179

  Capoluongo, Ettore ^a,b   Vento, G ^a   Lulli, P ^a   Di Stasio, E ^a   Porzio, S ^a   Vendettuoli, V ^a   Tana, M ^a   Tirone, C ^a   Romagnoli, C ^a   Zuppi, C ^a   Ameglio, F ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

BPD; MMP 9; NGAL; Prematurity

Indexed keywords

GELATINASE B; IBUPROFEN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; FEMALE; HUMAN; LUNG DYSPLASIA; LUNG LAVAGE; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL;

EID: 41849145700     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100119     Document Type: Article

References (26)

1. Kjeldsen L., A.H. Johnsen, H. Sengelov and N. Borregaard. 1993. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268:10425.
2. Mori K. and K. Nakao. 2007. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 71:96.
3. Goetz D.H., S.T. Willie, R.S. Armen, T. Bratt, N. Borregaard and R.K. Strong. 2000. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 29:1935.
4. Page-McCaw A., A.J. Ewald and Z. Werb. 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8:221.
5. Bu D.X., A.L. Hemdahl, A. Gabrielsen, J. Fuxe, C. Zhu, P. Eriksson and Z.Q. Yan. 2006. Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB. Am. J. Pathol. 169:2245.
6. Bachorzewska-Gajewska H., J. Malyszko, E. Sitniewska, J.S. Malyszko and S. Dobrzycki. 2006. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am. J. Nephrol. 26:287.
7. Cowland J.B., T. Muta and N. Borregaard. 2006. IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J. Immunol. 176:5559.
8. Dik WA., A.H. van Kaam, T. Dekker, B.A. Naber, D.J. Janssen, A.A. Kroon, L.J. Zimmermann, M.A. Versnel and R. Lutter. 2006. Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome. Biol. Neonate 89:6.
9. Smith G.C.S. 1998. The pharmacology of the ductus arteriosus. Pharmacolog. Rev. 50:34.
10. Fortson W., K.D. Beharry, S. Nageotte, J.H. Sills, Y. Stavitsky, T. Asrat and H.D. Modanlou. 2006. Vaginal versus oral indomethacin in a rabbit model for non-infection-mediated preterm birth: an alternate tocolytic approach. Am. J. Obstet. Gynecol. 195:1058.
11. Ulug U., S. Goldman, I. Ben-Shlomo and E. Shalev. 2001. Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term decidua and fetal membranes: the effect of prostaglandin F(2alpha) and indomethacin. Mol. Hum. Reprod. 7:1187.
12. Buller K.M., Y. Xu and T.A. Day. 1998. Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1 beta. J. Neuroendocrinol. 1:519.
13. Garay-Rojas E., M. Harper, S. Hraba-Renevey and M. Kress. 1996. An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. Gene 8:173.
14. Roudkenar M.H., Y. Kuwahara, T. Baba, A.M. Roushandeh, S. Ebishima, S. Abe, Y. Ohkubo and M.J. Fukumoto. 2007. Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions. Radiat. Res. (Tokyo) 48:39.
15. Tong Z., X. Wu, D. Ovcharenko, J. Zhu, C.S. Chen and J.P. Kehren 2005. Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem. J. 151:441.
16. Sveger T., K. Ohlsson, H. Morse, S. Polberger and S. Laurin. 2003. Plasma neutrophil lipocalin, elastase-alpha1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome. Scand. J. Clin. Lab. Invest. 63:89.
17. Tambunting F., K.D. Beharry, J. Hartleroad, J. Waltzman, Y. Stavitsky and H.D. Modanlou. 2005. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia. Pediatr. Pulmonol. 39:5.
18. Sweet D.G., A.E. Curley, E. Chesshyre, J. Pizzotti, M.S. Wilbourn, H.L. Halliday and J.A. Warner. 2004. The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease. Acta Paediatr. 93:791.
19. Ekekezie I.I., D.W. Thibeault, S.D. Simon, M. Norberg, J.D. Merrill, R.A. Ballard, P.L. Ballard and W.E. Truog. 2004. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics 113:1709.
20. Vento G., P.G. Matassa, F. Ameglio, E. Capoluongo, E. Zecca, L. Tortorolo, M. Martelli and C. Romagnoli. 2005. HFOV in premature neonates: effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial. Intensive Care Med. 31:463.
21. Rennard S.I., G. Basset, D. Lecossier, K.M. O'Donnell, P. Pinkston and P.G. Martin. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532.
22. De Carolis M.P., C. Romagnoli, V. Polimeni, F. Piersigilli, E. Zecca, P. Papacci, A. Delogu and G. Tortorolo. 2000. Prophylactic Ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur. J. Pediatr. 159:364.
23. Shennan A.T., M.S. Dunn, A. Ohlsson, K. Lennox and E.M. Hoskins. 1988. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 82:527.
24. Asikainen T.M., A. Ahmad, B.K. Schneider and C.W. White. 2005. Effect of preterm birth on hypoxia-inducible factors and vascular endothelial growth factor in primate lungs. Pediatr. Pulmonol. 40:538.
25. Asikainen T.M., L.Y. Chang, J.J. Coalson, B.K. Schneider, N.S. Waleh, M. Ikegami, J.M. Shannon, V.T. Winter, P. Grubb, R.I. Clyman, B.A. Yoder, J.D. Crapo and C.W. White. 2006. Improved lung growth and function through hypoxia-inducible factor in primate chronic lung disease of prematurity. FASEB J. 20:986.
26. Capoluongo E., G. Vento, F. Ameglio, P. Lulli, P.G. Matassa, C. Carrozza, S.A. Santini, M. Antenucci, M. Castagnola, B. Giardina, C. Romagnoli and C. Zuppi. 2006. Increased levels of IGF-1 and beta2-microglobulin in epithelial lining fluid of preterm newborns developing chronic lung disease. effects of rhG-CSF. Int. J. Immunopathol. Pharmacol. 19:57.